Hercules (Drug Discovery) Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Latest Deal Amount
  • $5M

  • Investors
  • 5

Hercules (Drug Discovery) General Information

Description

Developer of aryl hydrocarbon receptor (AhR) inhibitors intended to orally treat solid tumors and viral infections. The company develops small molecule inhibitors that target the AhR pathway to modulate immune response and inhibit tumor growth and viral replication, enabling patients to access oral drug therapies.

Contact Information

Website
www.hercules-pharma.nl
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Galileiweg 8
  • 2333 BD Leiden
  • Netherlands
+31 06
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Galileiweg 8
  • 2333 BD Leiden
  • Netherlands
+31 06

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hercules (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC $5M Cancelled Pre-Clinical Trials
5. Later Stage VC 06-Aug-2020 Completed Pre-Clinical Trials
4. Debt - General 23-Aug-2017 Completed Pre-Clinical Trials
3. Early Stage VC Completed Pre-Clinical Trials
2. Grant 02-Nov-2015 $3.92M Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2013 Completed Startup
To view Hercules (Drug Discovery)’s complete valuation and funding history, request access »

Hercules (Drug Discovery) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of aryl hydrocarbon receptor (AhR) inhibitors intended to orally treat solid tumors and viral infections. The
Drug Discovery
Leiden, Netherlands
2 As of 2022

Boston, MA
 

Yardley, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hercules (Drug Discovery) Competitors (7)

One of Hercules (Drug Discovery)’s 7 competitors is Avalyn Pharma, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Avalyn Pharma Formerly VC-backed Boston, MA
Savara Formerly VC-backed Yardley, PA
Amgen Formerly PE-Backed Thousand Oaks, CA
Bristol-Myers Squibb Corporation Princeton, NJ
Biogen Formerly VC-backed Cambridge, MA
You’re viewing 5 of 7 competitors. Get the full list »

Hercules (Drug Discovery) Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Hercules (Drug Discovery) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3827824-A1 Treatment of congenital zika virus syndrome Inactive 26-Nov-2019
WO-2021089721-A1 Treatment, amelioration or prevention of a viral infection. Inactive 05-Nov-2019

Hercules (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hercules (Drug Discovery) Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
InnovationQuarter Venture Capital Minority
Pharma Connect Capital Venture Capital Minority
Eurostars Other Minority
Boston University University
Prides Crossing Capital Asset Manager Minority
To view Hercules (Drug Discovery)’s complete investors history, request access »

Ready to get started?

Request a free trial

Hercules (Drug Discovery) FAQs

  • When was Hercules (Drug Discovery) founded?

    Hercules (Drug Discovery) was founded in 2013.

  • Where is Hercules (Drug Discovery) headquartered?

    Hercules (Drug Discovery) is headquartered in Leiden, Netherlands.

  • What is the size of Hercules (Drug Discovery)?

    Hercules (Drug Discovery) has 2 total employees.

  • What industry is Hercules (Drug Discovery) in?

    Hercules (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Hercules (Drug Discovery) a private or public company?

    Hercules (Drug Discovery) is a Private company.

  • What is Hercules (Drug Discovery)’s current revenue?

    The current revenue for Hercules (Drug Discovery) is .

  • How much funding has Hercules (Drug Discovery) raised over time?

    Hercules (Drug Discovery) has raised $1.87M.

  • Who are Hercules (Drug Discovery)’s investors?

    InnovationQuarter, Pharma Connect Capital, Eurostars, Boston University, and Prides Crossing Capital have invested in Hercules (Drug Discovery).

  • Who are Hercules (Drug Discovery)’s competitors?

    Avalyn Pharma, Savara, Amgen, Bristol-Myers Squibb, and Biogen are some of the 7 competitors of Hercules (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process